Randy Glein and Kevin Tu give insight into DFJ Growth's investment in Anduril and why they feel it is one of the most important companies of our era, boldly innovating and ushering in a new wave of defense tech.
More >
ANDURIL — THE DEFENSE THAT NEVER RESTS
THE ORACLE OF DELFI: FINDING EVERY CANCER EARLY
We are excited to announce DFJ Growth’s investment in Delfi Diagnostics, where we led the company’s $225 million Series B financing.
More >
More >
VANNEVAR: DECRYPTING DEFENSE
We are thrilled to announce our investment in Vannevar’s $75 million Series B as part of our expanding thesis and growing portfolio in the defense technology sector.
More >
More >